Evidence map›Paper›PMID 36292647›Full record

ReviewGenes2022

From Genotype to Phenotype-A Review of Kabuki Syndrome.

Kelly K Barry, Michaelangelo Tsaparlis, Deborah Hoffman, Deborah Hartman, Margaret P Adam, Christina Hung, Olaf A Bodamer

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. A rare cause of liver cirrhosis in an adult.Gastroenterology report · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Long-term kidney outcomes in patients with Kabuki syndrome.Pediatric nephrology (Berlin, Germany) · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Kelly K BarryTufts University School of Medicine, Boston, MA 02111, USA.ORCID 0000-0003-0382-4470
Michaelangelo TsaparlisDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA.
Deborah HoffmanTakeda Pharmaceuticals, Cambridge, MA 02139, USA.
Deborah HartmanOrexia Therapeutics, Boston, MA 02115, USA.
Margaret P AdamDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Christina HungDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA.
Olaf A BodamerDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-7847-552X
Boston Children's Hospital · USBroad Institute · USTakeda (United States) · USTufts University · USUniversity of Washington · USXilio Therapeutics (United States) · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
NICHD NIH HHS P50 HD105351
6 · The paper itself

Abstract

Kabuki syndrome (KS) is a rare neuro-developmental disorder caused by variants in genes of histone modification, including

Indexed as

Histone DemethylasesQuality of LifeAbnormalities, MultipleFaceGenotypeHematologic DiseasesPhenotypeVestibular DiseasesHistone DemethylasesKabuki syndromeKDM6AKMT2DNiikawa–Kuroki syndrometranscription

Identifiers

PMID36292647
PMCPMC9601850
OpenAlexW4297973216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.